Andrew Tsai
About Andrew Tsai
Andrew Tsai is the Senior Vice President at Jefferies, specializing in biotech equity research in the San Francisco Bay Area.
Current Role at Jefferies
Andrew Tsai is currently serving as the Senior Vice President at Jefferies, a role he has held since 2017. Based in the San Francisco Bay Area, he works with Senior Analyst Michael Yee in an Institutional Investor-ranked biotech research team. His responsibilities include leading coverage on various biotech companies, including MRNS, SAGE, ITCI, and ZYNE. He specializes in equity research with a primary focus on the biotechnology sector.
Previous Experience at Wells Fargo Securities
Before joining Jefferies, Andrew Tsai worked at Wells Fargo Securities as an Associate Analyst from 2016 to 2017. He spent five months in this role, based in the San Francisco Bay Area. His job involved equity research and analysis.
Roles at RBC Capital Markets and Wedbush Securities
Andrew Tsai has experience working as a Senior Equity Research Associate at RBC Capital Markets from 2015 to 2016. Prior to that, he served as an Equity Research Associate at Wedbush Securities from 2013 to 2015. Both roles were based in the San Francisco Bay Area and involved comprehensive equity research and analysis with a concentration on the biotech sector.
Education and Degrees
Andrew Tsai holds a Master of Science (MS) degree in Environmental/Environmental Health Engineering from Stanford University, a program he completed from 2012 to 2013. He also earned a Bachelor of Science (BS) degree in Environmental/Environmental Health Engineering from UC Irvine, graduating in 2011 after four years of study from 2007 to 2011.
Early Career as Retail Stock Investor
From 2006 to 2013, Andrew Tsai was self-employed as a Retail Stock Investor based in Cupertino, CA. During this seven-year period, he gained valuable experience in stock market investments, setting the foundation for his future roles in equity research and analysis.